These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 11569415

  • 1. [Regression of hCG in various types of molar pregnancies--clinical course and prognosis].
    Rob L, Robová H, Pluta M, Kulovaný E, Hrehorcák M, Chmel R, Schlegerová D, Kodet R, Macek M.
    Ceska Gynekol; 2001 Jul; 66(4):230-5. PubMed ID: 11569415
    [Abstract] [Full Text] [Related]

  • 2. [Molar pregnancy (primary or recurrent?)].
    Ayala A, Aizpuru E, Tovar JM.
    Ginecol Obstet Mex; 1989 Aug; 57():226-8. PubMed ID: 2562106
    [Abstract] [Full Text] [Related]

  • 3. Histopathological and clinical features of molar pregnancy.
    Heřman J, Rob L, Robová H, Drochýtek V, Hruda M, Pichlík T, Kujal P, Drozenová J.
    Ceska Gynekol; 2019 Aug; 84(6):418-424. PubMed ID: 31948249
    [Abstract] [Full Text] [Related]

  • 4. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
    Kizaki S, Matsui H, Usui H, Shozu M, Hanawa S, Yamamoto E, Kikkawa F.
    J Reprod Med; 2012 Aug; 57(5-6):243-8. PubMed ID: 22696820
    [Abstract] [Full Text] [Related]

  • 5. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MG.
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [Abstract] [Full Text] [Related]

  • 6. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 7. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J, Ohba T, Fukunaga M, Katabuchi H.
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [Abstract] [Full Text] [Related]

  • 8. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 9. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [Abstract] [Full Text] [Related]

  • 10. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
    Kerkmeijer LG, Massuger LF, Ten Kate-Booij MJ, Sweep FC, Thomas CM.
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
    [Abstract] [Full Text] [Related]

  • 11. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 12. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
    Schlaerth JB, Morrow CP, Kletzky OA, Nalick RH, D'Ablaing GA.
    Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
    [Abstract] [Full Text] [Related]

  • 13. Serum human placental lactogen (HPL) levels in patients with intact hydatidiform mole.
    Lim YC, Chew SC, Ratnam SS.
    Acta Obstet Gynecol Scand; 1976 Oct; 55(5):407-12. PubMed ID: 187001
    [Abstract] [Full Text] [Related]

  • 14. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR.
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [Abstract] [Full Text] [Related]

  • 15. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Albright BB, Shorter JM, Mastroyannis SA, Ko EM, Schreiber CA, Sonalkar S.
    Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
    [Abstract] [Full Text] [Related]

  • 16. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB, Hidayat YM, Winarno GNA, Nisa AS, Alkaff FF.
    Am J Case Rep; 2021 Jun 15; 22():e931156. PubMed ID: 34127641
    [Abstract] [Full Text] [Related]

  • 17. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb 15; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 18. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2005 Sep 15; 106(3):548-52. PubMed ID: 16135585
    [Abstract] [Full Text] [Related]

  • 19. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr 15; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM.
    Eur J Endocrinol; 2005 Oct 15; 153(4):565-75. PubMed ID: 16189178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.